Sc. Baraban et Pa. Schwartzkroin, ELECTROPHYSIOLOGY OF CA1 PYRAMIDAL NEURONS IN AN ANIMAL-MODEL OF NEURONAL MIGRATION DISORDERS - PRENATAL METHYLAZOXYMETHANOL TREATMENT, Epilepsy research, 22(2), 1995, pp. 145-156
Prenatal methylazoxymethanol acetate (MAMac) injection disrupts cell m
igration in developing rats. We investigated the electrophysiological
characteristics of hippocampal CA1 pyramidal neurons from young MAMac-
treated animals (postnatal days 25-35). In vitro intracellular recordi
ngs from CA1 cells in MAMac-treated tissue revealed resting membrane p
otential (mean, -61.5 +/- 1.5 mV), action potential amplitude (mean, 6
9 +/- 3.1 mV), action potential duration (mean, 2.1 +/- 0.2 ms), input
resistance (mean, 51.5 +/- 3.6 M Omega) and time constant (mean, 33.2
+/- 1.2 ms) similar to those of CA1 cells from control tissue. Howeve
r, MAMac-treated tissue could be distinguished as having a higher perc
entage of cells (62% vs. 10%) which fire a burst of action potentials
in response to suprathreshold current injection. The synaptic response
s of CA1 cells in MAMac-treated and control tissue were comparable. Th
e CA1 field response to stimulation was also comparable at all stimulu
s intensities tested (50-1500 mu A). Elevation of extracellular potass
ium concentration ([K+](0)) from 3 mM to 6 mM resulted in epileptiform
discharge activity in response to stratum radiatum stimulation in all
MAMac-treated slices (10/10) but in only one-third of controls (3/9).
Spontaneous epileptiform discharges were also observed in the majorit
y (8/13) of MAMac-treated slices bathed in 6 mM KCI but in no controls
. These data suggest that MAMac treatment during fetal development not
only disrupts normal anatomical organization but also leads to altera
tions in electrophysiological features of the hippocampal CA1 pyramida
l cell region. As such, the MAMac model may provide insights into earl
y onset seizure syndromes associated with developmental abnormalities.